Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method

Journal of Virology

Volumn 79, Issue 3, 2005, Pages 1813-1823

  Chou, Yu Chi ^a   Jeng, King Song ^e   Chen, Mong Liang ^b,f   Liu, Hsiao Hui ^d   Liu, Tzu Ling ^b   Chen, Ya Ling ^b   Liu, Yu Chih ^a   Hu, Cheng Po ^a,c   Chang, Chungming ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TECHNOLOGY AND SCIENCE INSTITUTE OF NORTHERN TAIWAN   (Taiwan)

^e INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^f NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; COVALENTLY CLOSED CIRCULAR DNA; UNCLASSIFIED DRUG; ENDODEOXYRIBONUCLEASE BCLI; HEPATITIS B VIRUS X PROTEIN; TRANSACTIVATOR PROTEIN; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; VIRUS DNA;

ARTICLE; CHRONIC HEPATITIS; GENETIC TRANSCRIPTION; HEPATITIS B; HEPATITIS B VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; VIRUS GENOME; VIRUS HEPATITIS; EVALUATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA, CIRCULAR; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS B VIRUS; HUMANS; RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 13744253278     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.3.1813-1823.2005     Document Type: Article

References (44)

1. Abdelhamed, A. M., C. M. Kelley, T. G. Miller, P. A. Furman, and H. C. Isom. 2002. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J. Virol. 76:8148-8160.
2. Arii, M., S. Takada, and K. Koike. 1992. Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene 7:397-403.
3. Ben-Levy, R., O. Faktor, I. Berger, and Y. Shaul. 1989. Cellular factors that interact with the hepatitis B virus enhancer. Mol. Cell. Biol. 9:1804-1809.
4. Benn, J., and R. J. Schneider. 1994. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc. Natl. Acad. Sci. USA 91:10350-10354.
5. Benn, J., F. Su, M. Doria, and R. J. Schneider. 1996. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J. Virol. 70:4978-4985.
6. Bock, C. T., S. Schwinn, S. Locarnini, J. Fyfe, M. P. Manns, C. Trautwein, and H. Zentgraf. 2001. Structural organization of the hepatitis B virus minichromosome. J. Mol. Biol. 307:183-196.
7. 1 transit via a Src kinase pathway. J. Virol. 75:4247-4257.
8. Buendia, M. A. 1998. Hepatitis B viruses and cancerogenesis. Biomed. Pharmacother. 52:34-43.
9. Caselmann, W. H. 1995. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. J. Hepatol. 22:34-37.
10. Chen, H. S., S. Kaneko, R. Girones, R. W. Anderson, W. E. Hornbuckle, B. C. Tennant, P. J. Cote, J. L. Gerin, R. H. Purcell, and R. H. Miller. 1993. The woodchuclc hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 67:1218-1226.
11. Chiaramonte, M., T. Stroffolini, A. Vian, M. A. Stazi, A. Floreani, U. Lorenzoni, S. Lobello, F. Farinati, and R. Naccarato. 1999. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 85:2132-2137.
12. Chisari, F. V. 2000. Viruses, immunity, and cancer, lessons from hepatitis B. Am. J. Pathol. 156:1117-1132.
13. Choi, B. H., G. T. Park, and H. M. Rho. 1999. Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. J. Biol. Chem. 274:2858-2865.
14. Choi, C. Y., B. H. Choi, G. T. Park, and H. M. Rho. 1997. Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer. J. Biol. Chem. 272:16934-16939.
15. Chou, H. W., D. Harrell, R. Forough, and K. Watabe. 1988. Binding of tissue-specific factors to the enhancer sequence of hepatitis B virus. FEBS Lett. 229:349-354.
16. Doria, M., N. Klein, R. Lucito, and R. J. Schneider. 1995. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J. 14:4747-4757.
17. Galibert, F., E. Mandart, F. Fitoussi, P. Tiollais, and P. Charnay. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646-650.
18. Ganem, D., J. R. Pollack, and J. Tavis. 1994. Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. Infect. Agents Dis. 3:85-93.
19. Henkler, F. F., and R. Koshy. 1996. Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis. J. Viral Hepat. 3:109-121.
20. Kao, J. H., and D. S. Chen. 2002. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2:395-403.
21. Kekule, A. S., U. Lauer, L. Weiss, B. Luber, and P. H. Hofschneider, 1993. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361:742-745.
22. Kock, J., T. F. Baumert, W. E. Delaney IV, H. E. Blum, and F. von Weizsacker, 2003. Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes. Hepatology 38: 1410-1418.
23. Kong, H. J., S. H. Hong, M. Y. Lee, H. D. Kim, J. W. Lee, and J. Cheong. 2000. Direct binding of hepatitis B virus X protein and retinoid X receptor contributes to phosphoenolpyruvate carboxykinase gene transactivation. FEBS Lett. 483:114-118.
24. Lau, D. T., M. F. Khokhar, E. Doo, M. G. Ghany, D. Herion, Y. Park, D. E. Kleiner, P. Schmid, L. D. Condreay, J. Gauthier, M. C. Kuhns, T. J. Liang, and J. H. Hoofnagle. 2000. Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 32:828-834.
25. Lin, Y., T. Nomura, J. Cheong, D. Dorjsuren, K. Iida, and S. Murakami. 1997. Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J. Biol. Chem. 272:7132-7139.
26. Lin, Y., H. Tang, T. Nomura, D. Dorjsuren, N. Hayashi, W. Wei, T. Ohta, R. Reeder, and S. Murakami. 1998. The hepatitis B virus X protein is a coactivator of activated transcription that modulates the transcription machinery and distal binding activators. J. Biol. Chem. 273:27097-27103.
27. Mason, W. S., J. Cullen, G. Moraleda, J. Saputelli, C. E. Aldrich, D. S. Miller, B. Tennant, L. Frick, D. Averett, L. D. Condreay, and A. R. Jilbert. 1998. Lamivudine therapy of WHV-infected woodchucks. Virology 245:18-32.
28. Moraleda, G., J. Saputelli, C. E. Aldrich, D. Averett, L. Condreay, and W. S. Mason. 1997. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J. Virol. 71:9392-9399.
29. Mosley, J. W., W. Huang, D. O. Stram, M. J. Nowicki, F. B. Hollinger, R. D. Aach, C. E. Stevens, L. H. Barbosa, and G. J. Nemo. 1996. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes. Transfusion 36:776-781.
30. Murakami, S. 2001. Hepatitis B virus X protein: a multifunctional viral regulator. J. Gastroenterol. 36:651-660.
31. Qadri, I. J. W. Conaway, R. C. Conaway, J. Schaack, and A. Siddiqui. 1996. Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc. Natl. Acad. Sci. USA 93:10578-10583.
32. Radziwill, G., W. Tucke, and H. Schaller. 1990. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J. Virol. 64:613-620.
33. Seeger, C., D. Ganem, and H. E. Varmus. 1986. Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science 232:477-484.
34. Seeger, C., and W. S. Mason. 2000. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64:51-68.
35. Sells, M. A., M. L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84:1005-1009.
36. Sells, M. A., A. Z. Zelent, M. Shvartsman, and G. Acs. 1988. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62:2836-2844.
37. Simonsen, C. C., and A. D. Levinson. 1983. Analysis of processing and polyadenylation signals of the hepatitis B virus surface antigen gene by using simian virus 40-hepatitis B virus chimeric plasmids. Mol. Cell. Biol. 3:2250-2258.
38. Takada, S., and K. Koike. 1994. Three sites of the hepatitis B virus X protein cooperatively interact with cellular proteins. Virology 205:503-510.
39. Truant, R., J. Antunovic, J. Greenblatt, C. Prives, and J. A. Cromlish. 1995. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J. Virol. 69:1851-1859.
40. Tuttleman, J. S., C. Pourcel, and J. Summers. 1986. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47:451-460.
41. Unger, T., and Y. Shaul. 1990. The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element: EMBO J. 9:1889-1895.
42. Wu, T. T., L. Coates, C. E. Aldrich, J. Summers, and W. S. Mason. 1990. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 175:255-261.
43. 1 phase dependent nuclear localization of relaxed-circular hepatitis B virus DNA and aphidicolin-induced accumulation of covalently closed circular DNA. J. Med. Virol. 55:42-50.
44. Zoulim, F., J. Saputelli, and C. Seeger. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68:2026-2030.